Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4767993

O=C(/C=C/c1ccc(F)cc1)Nc1ccc2c(c1)CCN(C1CCC1)CC2.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.51
MAOB P27338 2/20 0.47
DRD2 P14416 4/20 0.45
DRD3 P35462 4/20 0.45
MMP1 P03956 3/20 0.45
MMP2 P08253 3/20 0.45
MMP9 P14780 3/20 0.45
MAPT P10636 2/20 0.45
EGFR P00533 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
APP P05067 1/20 0.42
MCHR1 Q99705 2/20 0.42
HRH3 Q9Y5N1 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HTR1D P28221 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4768005 1.00 TRPV1 (0.51) TRPV1MAOBDRD2DRD3MMP1
SCHEMBL4774758 0.94 TRPV1 (0.53) TRPV1MAOBDRD2DRD3MMP1
SCHEMBL4774745 0.94 TRPV1 (0.53) TRPV1MAOBDRD2DRD3MMP1
Trifluoroacetic Acid SCHEMBL4774472 0.93 TRPV1 (0.50) TRPV1MAOBMMP1MMP2MMP9
Trifluoroacetic Acid SCHEMBL4774480 0.93 TRPV1 (0.50) TRPV1MAOBMMP1MMP2MMP9
Trifluoroacetic Acid SCHEMBL4770275 0.90 IMPDH2 (0.52) TRPV1MAOBDRD2DRD3MMP1
Trifluoroacetic Acid SCHEMBL4770261 0.90 IMPDH2 (0.52) TRPV1MAOBDRD2DRD3MMP1
Trifluoroacetic Acid SCHEMBL4765269 0.89 MAPT (0.51) TRPV1DRD2DRD3MMP1MMP2
Trifluoroacetic Acid SCHEMBL4766896 0.89 MAPT (0.51) TRPV1DRD2DRD3MMP1MMP2
SCHEMBL4773020 0.86 TRPV1 (0.53) TRPV1MAOBMMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 TRPV1 125/4885MAOB 151/4885DRD2 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.